Siemens - February 05th, 2019
General: The IPO of Siemens Healthineers was conducted on 16 March 2018 at an issue price of EUR 28.00. In total, 150m shares, representing a free float of 15%, were placed by Siemens AG, which received the resulting proceeds and continues to own 85% of the Company's shares.
Siemens Healthineers is a leading medical technology company and global provider of healthcare solutions and services with over 170 years of experience and 18,000 patents.
As of 30 September 2018, Siemens Healthineers had about 50,000 employees in over 70 countries. In financial year 2017/2018, the Company generated revenues of EUR 13.4bn.
Item 4a: The remuneration system for the Management Board has not yet been put to shareholder approval. Although the level of actual remuneration in financial year 2017/2018 is not considered to be excessive, we urge the Company to submit the remuneration system to shareholder approval at the next AGM. In line with our guidelines we recommend to oppose the discharge of the Chairman of the Supervisory Board's Chairman's Committee, Michael Sen.
Siemens is a technology company. Co.'s Energy sector provides a range of products, solutions and services for generating and transmitting power. The Healthcare sector provides customers a range of medical solutions across the treatment chain. The Industry sector supplies products and solutions for industrial companies, primarily in the process and manufacturing industries. The Infrastructure & Cities sector provides a range of technologies that accelerates the capabilities of metropolitan centers and urban infrastructures. The Investments segment is comprised of Co.'s equity stakes in other companies. The Financial Services segment provides business-to-business financial solutions.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.